We’re thrilled to report that the Care Trial has reached 95% of it’s recruitment target.
Care Study site teams across the country have successfully recruited 57 participants for the first ever pilot #clinicaltrial for #cavernoma. There are now only 3 participants left to recruit before the end of April.
In case you didn’t already know, this research study wants to find out what approach is best for treatment of people with a brain cavernoma that has caused symptoms like stroke or epileptic seizure. The study seeks to determine whether active treatment (via surgery or targeted radiation treament) or conservative management (treating symptoms alone on a ‘watch & wait’ basis) is more effective for symptomatic cavernoma.
As always, we will continue to update you as the trial progresses. In the meantime, we are here to support anyone currently involved in this clinical trial.
CAUK does not endorse any form of management or treatment for cavernoma, nor any medication. Any individual's treatment, management or medication should be discussed with your doctor (GP, clinician) or other health-care provider.